Mesenchymal stem cell-derived apoptotic bodies alleviate alveolar bone destruction by regulating osteoclast differentiation and function.
10.1038/s41368-023-00255-y
- Author:
Xiaoyan LI
1
;
Yiyang JIANG
1
;
Xu LIU
1
;
Jingfei FU
1
;
Juan DU
1
;
Zhenhua LUO
1
;
Junji XU
1
;
Ujjal Kumar BHAWAL
2
;
Yi LIU
3
;
Lijia GUO
4
Author Information
1. Laboratory of Tissue Regeneration and Immunology and Department of Periodontics, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, School of Stomatology, Capital Medical University, Beijing, China.
2. Research Institute of Oral Science, Nihon University School of Dentistry at Matsudo, Chiba, Japan. bhawal.ujjal.kumar@nihon-u.ac.jp.
3. Laboratory of Tissue Regeneration and Immunology and Department of Periodontics, Beijing Key Laboratory of Tooth Regeneration and Function Reconstruction, School of Stomatology, Capital Medical University, Beijing, China. lililiuyi@163.com.
4. Department of Orthodontics School of Stomatology, Capital Medical University, Beijing, China. drguolijia@163.com.
- Publication Type:Journal Article
- MeSH:
Humans;
Osteoclasts;
Alveolar Bone Loss/therapy*;
Cell Differentiation;
MicroRNAs;
Periodontitis/therapy*;
Extracellular Vesicles;
Apoptosis;
Mesenchymal Stem Cells
- From:
International Journal of Oral Science
2023;15(1):51-51
- CountryChina
- Language:English
-
Abstract:
Periodontitis is caused by overactive osteoclast activity that results in the loss of periodontal supporting tissue and mesenchymal stem cells (MSCs) are essential for periodontal regeneration. However, the hypoxic periodontal microenvironment during periodontitis induces the apoptosis of MSCs. Apoptotic bodies (ABs) are the major product of apoptotic cells and have been attracting increased attention as potential mediators for periodontitis treatment, thus we investigated the effects of ABs derived from MSCs on periodontitis. MSCs were derived from bone marrows of mice and were cultured under hypoxic conditions for 72 h, after which ABs were isolated from the culture supernatant using a multi-filtration system. The results demonstrate that ABs derived from MSCs inhibited osteoclast differentiation and alveolar bone resorption. miRNA array analysis showed that miR-223-3p is highly enriched in those ABs and is critical for their therapeutic effects. Targetscan and luciferase activity results confirmed that Itgb1 is targeted by miR-223-3p, which interferes with the function of osteoclasts. Additionally, DC-STAMP is a key regulator that mediates membrane infusion. ABs and pre-osteoclasts expressed high levels of DC-STAMP on their membranes, which mediates the engulfment of ABs by pre-osteoclasts. ABs with knock-down of DC-STAMP failed to be engulfed by pre-osteoclasts. Collectively, MSC-derived ABs are targeted to be engulfed by pre-osteoclasts via DC-STAMP, which rescued alveolar bone loss by transferring miR-223-3p to osteoclasts, which in turn led to the attenuation of their differentiation and bone resorption. These results suggest that MSC-derived ABs are promising therapeutic agents for the treatment of periodontitis.
